Shayan Abdollah Zadegan1, Aidin Abedi1, Seyed Behnam Jazayeri1, Hirbod Nasiri Bonaki1, Seyed Behzad Jazayeri1, Alexander R Vaccaro2, Vafa Rahimi-Movaghar3. 1. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran. 2. Department of Orthopedics and Neurosurgery, The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, USA. 3. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran. Electronic address: V_rahimi@sina.tums.ac.ir.
Abstract
OBJECTIVE: Bone morphogenetic proteins (BMPs) have been commonly used as a graft substitute in spinal fusion. Although the U.S. Food and Drug Administration issued a warning on life-threatening complications of recombinant human BMPs (rhBMPs) in cervical spine fusion in 2008, their off-label use has been continued. This investigation aimed to review the evidence for the use of rhBMP-2 and rhBMP-7 in anterior cervical spine fusions. METHODS: A comprehensive search was performed through Ovid (MEDLINE), PubMed, and Embase. The risk of bias assessment was according to the recommended criteria by the Cochrane Back and Neck group and MINORS (Methodological Index for Non-Randomized Studies). A wide array of radiographic and clinical outcomes including the adverse events were collated. RESULTS: Eighteen articles (1 randomized and 17 nonrandomized) were eligible for inclusion. The fusion rate was higher with use of rhBMP in most studies and our meta-analysis of the pooled data from 4782 patients confirmed this finding (odds ratio, 5.45; P < 0.00001). Altogether, the rhBMP and control groups were comparable in patient-reported outcomes. However, most studies tended to show a significantly higher incidence of overall complication rate, dysphagia/dysphonia, cervical swelling, readmission, wound complications, neurologic complications, and ossification. CONCLUSIONS: Application of rhBMPs in cervical spine fusion yields a significantly higher fusion rate with similar patient-reported outcomes, yet increased risk of life-threatening complications. Thus, we do not recommend the use of rhBMP in anterior cervical fusions.
OBJECTIVE: Bone morphogenetic proteins (BMPs) have been commonly used as a graft substitute in spinal fusion. Although the U.S. Food and Drug Administration issued a warning on life-threatening complications of recombinant human BMPs (rhBMPs) in cervical spine fusion in 2008, their off-label use has been continued. This investigation aimed to review the evidence for the use of rhBMP-2 and rhBMP-7 in anterior cervical spine fusions. METHODS: A comprehensive search was performed through Ovid (MEDLINE), PubMed, and Embase. The risk of bias assessment was according to the recommended criteria by the Cochrane Back and Neck group and MINORS (Methodological Index for Non-Randomized Studies). A wide array of radiographic and clinical outcomes including the adverse events were collated. RESULTS: Eighteen articles (1 randomized and 17 nonrandomized) were eligible for inclusion. The fusion rate was higher with use of rhBMP in most studies and our meta-analysis of the pooled data from 4782 patients confirmed this finding (odds ratio, 5.45; P < 0.00001). Altogether, the rhBMP and control groups were comparable in patient-reported outcomes. However, most studies tended to show a significantly higher incidence of overall complication rate, dysphagia/dysphonia, cervical swelling, readmission, wound complications, neurologic complications, and ossification. CONCLUSIONS: Application of rhBMPs in cervical spine fusion yields a significantly higher fusion rate with similar patient-reported outcomes, yet increased risk of life-threatening complications. Thus, we do not recommend the use of rhBMP in anterior cervical fusions.
Authors: Amit Jain; Majd Marrache; Andrew Harris; Varun Puvanesarajah; Brian J Neuman; Zorica Buser; Jeffrey C Wang; S Tim Yoon; Hans Jörg Meisel Journal: Global Spine J Date: 2019-10-25
Authors: Cliff Lin; Nianli Zhang; Erik I Waldorff; Paolo Punsalan; David Wang; Eric Semler; James T Ryaby; Jung Yoo; Brian Johnstone Journal: JOR Spine Date: 2020-03-15
Authors: Jacob L Goldberg; Ross M Meaden; Ibrahim Hussain; Pravesh S Gadjradj; Danyal Quraishi; Fabian Sommer; Joseph A Carnevale; Branden Medary; Drew Wright; K Daniel Riew; Roger Hartl Journal: Brain Spine Date: 2022-08-22